BACKGROUND: Acute mesenteric ischemia (AMI) is associated with a high mortality rate, yet diagnostic difficulties persist. Although many biomarkers have been investigated for diagnostic purposes, as well as imaging methods, a sufficiently specific and sensitive marker has not been identified. This research was designed to examine whether heparin-binding protein (HBP), which has a role in the early phase of inflammation, could be useful in the diagnosis of AMI.
INTRODUCTION
Mesenteric ischemia (MI) is less commonly observed in emergency units compared with other causes of abdominal pathology, but should be diagnosed quickly due to its high mortality risk. The most important step in the management of the disease is the diagnosis. Despite advanced radiological and surgical techniques, acute mesenteric ischemia (AMI) is still a disease with high mortality rate. [1] [2] [3] [4] Prognosis is significantly improved by the reinstatement of the blood flow within the first 6 hours of ischemia, and particularly embolism-related ischemia. The prognosis is wors-Cite this article as: Koçak S, Acar T, Ertekin B, Güven M, Dündar ZD. The role of heparin-binding protein in the diagnosis of acute mesenteric ischemia. Ulus Travma Acil Cerrahi Derg 2019; 25:205-212. of the neutrophils. Its potential role in infectious diseases has long been known and many studies have been conducted on the subject. In a recent study, HBP was demonstrated to be the only component of neutrophils that provokes increased permeability in in-vitro endothelial cell monolayers and invivo vascular endothelium. [7] HBP also has proinflammatory chemotactic effects against monocytes and T cells. HBP is easily mobilized within neutrophils, and this process or other functions of HBP appear to be important in early inflammation processes. [8] Clinical studies suggest HBP could be predictive in the progress of organ dysfunction, sepsis, and septic shock in patients admitted to emergency units with suspected infections and in intensive care patients. [9, 10] Bacterial translocation develops in AMI, which in turn, initiates the inflammatory process. Inflammatory markers, including biomarkers, have been widely studied in AMI due to the inflammation accompanied by ischemia. The aim of this study was to analyze the blood level of HBP in AMI, which has not been studied before, and to evaluate its diagnostic potential compared with current markers. HBP may be a beneficial molecule in the early diagnosis of AMI since it has a role in the early stage of inflammation. In the present study, an experimental rabbit model of AMI was constructed and HBP, C-reactive protein (CRP) and interleukin 6 (IL-6) levels were measured at specific intervals. The change in the level of these biomarkers over time and their relationship to each other were compared statistically, and their roles in the diagnosis of AMI were evaluated.
MATERIALS AND METHODS
No new animal experiment was performed in the study. The serum samples obtained by Acar et al. [11] were used for the present research. That study was approved by the Laboratory Animals Ethical Committee of Necmettin Erbakan University Experimental Medicine Research and Practice Center on January 20, 2012 (reg. no 2012-01) and conducted at Necmettin Erbakan University Experimental Medicine Research and Practice Center in May 2012. The present study was approved by the same committee on April 17, 2013 (reg. no 2013-073). The methods applied in the original study are described in detail in the published report. As a summary:
Experimental Protocol
The study included 27 adult male and female New Zealand rabbits weighing 2500 to 3000 g. All of the animals had the same environment and nutritional conditions. Prior to the experimental study, food was withheld for 12 hours and only water was provided. The animals were classified into 3 groups: a control group of 7 rabbits, a sham group of 10 rabbits, and an ischemia group of 10 rabbits.
Control group (Group I):
A dose of 50 mg/kg ketamine and 15 mg/kg xylazine was administered via the intramuscular route through the hind leg, and following attainment of anes-thesia, vascular access at the dorsal ear vein of the animals was used to obtain blood samples and perform an infusion with a 22-G intravascular catheter. Blood samples of 5 mL were collected in Vacutainer gel tubes (Becton Dickinson and Co., Franklin Lakes, NJ, USA) at baseline and the first, third, and sixth hours for biochemical analysis. Following each sampling, 5 mL of 0.9% physiological saline was infused through the same catheter.
Sham group (Group II):
The same procedure was applied to the rabbits in this group as in the control group. Following blood sampling for the baseline value, the abdominal region of the animals was shaved and cleaned with 10% povidone iodine. A laparotomy was performed via a midline incision, and when the peritoneum was accessed, the abdominal wall and peritoneum were closed using 2/0 silk sutures. Blood samples were collected at the first, third, and sixth hours for biochemical evaluation. Following each sampling, 5 mL of 0.9% physiological saline was infused through the same catheter, as in the control group.
Ischemia group (Group III):
The same preparation that was described for the rabbits in the sham group was used in the ischemia group. Following blood sampling for the baseline value, a laparotomy was performed via midline incision, and the superior mesenteric artery was found and ligated. The peritoneum and abdominal wall were closed using 2/0 silk. Blood samples were collected at the postoperative first, third, and sixth hours for biochemical analysis. Following each sampling, 5 mL of 0.9% physiological saline was infused through the same catheter. At the end of the 6-hour ischemia period, the rabbits were sacrificed with a high dose of ketamine.
Storage of the Samples
The 5 mL blood samples collected in Vacutainer gel tubes were held for 30 minutes for coagulation, and centrifuged at 3000 rpm for 10 minutes. The serum samples were pipetted in Eppendorf tubes (Eppendorf AG, Hamburg, Germany) and kept at -80°C until biochemical analysis.
Evaluation of the Samples Biochemical Analysis
Enzyme-linked immunosorbent assay (ELISA) tests and ready-to-use commercial kits were used for all 3 markers. The Sunred Rabbit Heparin Binding Protein (HBP) ELISA Kit (Lot No: 201090291; Shanghai Sunred Biological Technology Co., Ltd, Shanghai, China) was used for the measurement of serum HBP levels, the Scientific Research Special Eastbiopharm Rabbit CRP ELISA kit (Lot No: 20121024; Hangzhou Eastbiopharm Co. Ltd., Hangzhou, China) was used for the measurement of CRP levels, and the Cusabio Rabbit Interleukin-6 (IL-6) ELISA kit (Lot No: I4061791; Cusabio Biotech Co., Ltd, Wuhan, China) was used for measurement of IL-6 levels.
Statistical Analysis
Data were recorded on prepared forms. SPSS for Windows, Version 16.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. Variance analysis with a post hoc Tukey test was used to examine the measurements between groups. A Bonferroni-corrected paired T-test was used to determine the difference between measurements. Non-normally distributed ordinary variables were analyzed using the Friedman test. A Bonferroni-corrected Mann-Whitney U test was used to determine the difference between measurements. A p value of <0.05 was accepted as statistically significant. The results were presented in tables and graphs.
RESULTS
One of the rabbits in the ischemia group died at the first hour and therefore it was excluded. The study was completed with 26 rabbits.
Biochemical Markers CRP
The mean CRP level measured from the blood samples collected at baseline and the first, third and sixth hours in each group and the comparisons are illustrated in Table 1 . The initial values were somewhat lower in the sham group than in the control group (p<0.007). No significant difference was detected between groups in the levels at the first hour (p>0.05). The CRP levels measured at the third and sixth hours revealed no significant difference between the sham and control groups (p=0.994 and p=0.932, respectively), whereas a significant increase was observed in the ischemia group compared with both the control and sham groups (p=0.0001 and p=0.0001, respectively). The change in CRP level over time is presented in Fig. 1 . A progressive increase in the CRP level is notable in the sham group and particularly in the ischemia group.
IL-6
The mean IL-6 level measured from the blood samples collected at baseline and the first, third, and sixth hours in each group and the comparisons are demonstrated in Table 2 . No significant difference was detected between the groups with regard to the levels at baseline and the first hour (p>0.05). The IL-6 levels measured at the third and sixth hours revealed no significant difference between the sham and control groups (p=0.882 and p=0.775, respectively), whereas a significant increase was observed in the ischemia group compared with both the control (p=0.005 and p=0.0001, respectively) and sham groups (p=0.0008 and p=0.0001, respectively) at both the third and sixth hours. The change in IL-6 level over time is presented in Fig. 2 . The increase in IL-6 level in the ischemia group is notable.
HBP
The mean HBP level measured from the blood samples collected at baseline and the first, third, and sixth hours in each group and the comparisons are provided in Table 3 . No significant difference was detected between groups in the levels at baseline or the first and third hours (p>0.05). A significant increase was observed in the HBP level of the ischemia group compared with both the control and sham groups at the sixth hour (p=0.0012 and p=0.0001, respectively). The change in HBP level over time is presented in Fig. 3 . The increase in HBP level over time was less significant compared with the increase in CRP and IL-6 levels.
DISCUSSION
The clinical findings of AMI arise from impaired perfusion, systemic inflammatory responses due to impaired microcirculation, and reperfusion damage. [12] At the cellular stage, ischemia leads to mitochondrial dysfunction, impaired ion transport, and intracellular acidosis. Alterations in membrane permeability and the secretion of free radicals and disintegrating enzymes result in cell death and necrosis. [12, 13] Many cells within the ischemic tissue, such as neutrophils, endothelial cells, monocytes, and platelets are activated. Many proinflammatory substances, including tumor necrosis factor (TNF), interleukins, platelet activating factor, and leukotrienes are secreted. As a result, the damage is related to leukocyte adhesion, platelet aggregation, and impaired nitric oxide production. [14] It has long been known that ischemia leads to bacterial translocation due to changes in vascular permeability within a short time. [15, 16] In this study, we investigated the possibility that HBP, which has been demonstrated to have antibacterial effects as well as effects on both inflammation and vascular permeability, could be a beneficial marker for early diagnosis of AMI. The animals in the ischemia group were found to have significantly higher HBP levels at the sixth hour of ischemia compared with those in the sham and control groups.
HBP is a member of the serin protease family. [17] Although it has no enzymatic activity, it is a multi-functional protein. It accumulates and activates monocytes, induces T cells, starts detachment of endothelial cells and fibroblasts and the homotypic accumulation of these cells. Furthermore, endocytosis of HBP into monocytes increases the production of lipopolysaccharide-derived TNF-α. [8] Other studies have suggested that internalized HBP protects endothelial cells against apoptosis. [18] HBP has been shown to play a specific role in mediating the change in vascular permeability that is stimulated by chemoattractant-induced polymorphonuclear leukocyte activation. [7] The localization of HBP duplicates within azurophilic granules and secreted vesicles indicates a possible role of the protein in neutrophils. The HBP localized in azurophilic granules is in close contact with internalized bacteria after the azurophil granules are fused with the phagosome. Again, the HBP secreted from the secretory vesicles has been reported to have important functions during early stages of inflammation.
Unfortunately, in more than 20 studies conducted of biomarkers, no ideal biomarker with a high sensitivity and specificity has been detected for the diagnosis of AMI. The serum phosphate level is one of the biochemical parameters researched for diagnostic value in AMI. In a study conducted on 20 rabbits, the serum phosphate levels were shown to increase Sham Ischemia in AMI. [19] Feretis et al. [20] demonstrated significantly higher serum phosphate levels in 18 patients with acute intestinal infarction compared with 24 patients without intestinal ischemia. In an intestinal ischemia study conducted on dogs, a significant increase in the phosphate level was observed in the fourth hour of ischemia. However, the authors noted that this had no benefit in early diagnosis, and that the increase in phosphate level was meaningful following the development of irreversible necrosis within the intestines. [21] Leo et al. [22] found in a study of 23 AMI patients that serum phosphate levels had no diagnostic or prognostic value.
Another marker used in AMI is amylase. It has been reported that amylase levels were found to be higher than normal in 27 of 52 patients diagnosed with AMI. [23] In a study that included patients with acute abdomen on admission and who were diagnosed with AMI that amylase was 25% specific and 63% sensitive. [24] In another study, the amylase levels of the patients with AMI were observed to be high starting at the third hour. [25] Amylase has been demonstrated to increase in many disorders included in the etiology of acute abdomen. Its single usage in AMI is controversial, however, and should be confirmed with other parameters. Alone, the sensitivity and specificity are low.
In the experimental study conducted by Kurt et al., [26] the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of D-dimer in AMI were found to be 88.8%, 90%, 88.8%, and 100%, respectively, and they concluded that D-dimer may be beneficial in the early diagnosis of AMI. In another experimental AMI study, procalcitonin (PCT) was demonstrated to significantly increase in blood starting in the first hour of ischemia. [27] In a study investigating the PCT level in intestinal strangulation, PCT levels were higher than normal in the group with strangulation. PCT levels were observed to increase at the 30 th and 60 th minutes of the study, and a significant increase was detected in the 120 th minute. [28] In a series that included 7 patients with AMI, the ischemia-modified albumin (IMA) level were observed to be significantly higher than that of healthy controls. [29] In another clinical study, the IMA level was measured in 26 patients, 12 of whom were diagnosed to have intestinal ischemia, and the IMA level was significantly elevated. High IMA levels were reported to have 100% sensitivity and 100% specificity in the diagnosis of intestinal ischemia. [30] In a study conducted on rabbits, the IMA level was found to significantly increase with additional ischemia time. [31] In a study of 61 patients with acute abdominal pain, serum intestinal fatty acid binding protein (IFABP) levels were significantly higher in cases with ischemic bowel disease. [32] In another study, true positivity was detected for high IFABP in 7 patients with intestinal ischemia, whereas false positivity was detected in 10. [33] Another study examined 21 patients with strangulated intestinal obstruction, 3 of whom had intestinal necrosis. The serum IFABP level was high in all of the patients with intestinal necrosis. [34] A meta-analysis determined that the sensitivity and specificity of the serum IFABP level in the diagnosis of intestinal ischemia was 72% (51-88%) and 73% (62-83%), respectively. [6] In the study conducted by Dundar et al., [35] no significant difference was detected between the serum IFABP level in control, sham, and ischemia groups. Furthermore, no significant difference was observed at the initial, first, third, and sixth hours of ischemia in the ischemia group.
A literature search revealed no study on the diagnostic or prognostic value of HBP on patients with AMI. The number of clinical studies on HBP is limited. Considering its effect on vascular permeability, studies investigating whether it could be a marker of acute respiratory or circulatory failure in serious infections and sepsis have become important.
Chew et al. [36] investigated the HBP level in 53 patients with septic and non-septic shock in the emergency unit, The HBP level was significantly higher among patients with shock compared with that of healthy or control patients with an infection (such as urinary infection, pneumonia, gastroenteritis), whereas no difference was observed between patients with septic and non-septic shock. Research performed by Linder et al. [9] investigating the predictive value of HBP in the progression to circulatory failure or septic shock in patients with a suspected infection or sepsis, the HBP level in patients with serious sepsis or septic shock was significantly higher compared with that of patients with non-serious sepsis. PCT, white blood cell count (WBC), CRP, IL-6, and lactate values were used for comparison in predicting the progression to serious sepsis and septic shock and were found to be lower than that of HBP. The sensitivity, specificity, NPD, PPD and receiver operating characteristic (ROC) curve values of HBP were higher than those of other markers. In another study, Linder et al., [10] investigated 759 patients admitted to emergency units with a suspected infection. In all, 674 were diagnosed with various infections, and among that group, 487 had no organ dysfunction at admission. During the study period (72 hours), 141 of the 487 developed organ dysfunction. The authors reported that blood samples were collected for measurement of HBP, WBC, PCT, CRP and lactate on admission and within 12 to 24 hours after admission and compared for their predictive value for serious sepsis and organ dysfunction. HBP was superior to the other markers in patients with organ failure both on admission and during the study in terms of sensitivity, specificity, NPD, PPD, and ROC values. HBP was reported to increase hours before organ dysfunction (median: 10.5 hours) and to have a higher odds ratio (OR: 20.5) for indicating progression to organ dysfunction in comparison with the other markers.
In another study investigating the relationship between reduced oxygenation and circulatory failure and the HBP level in intensive care patients, the HBP level on admission was found to be related to respiratory and circulatory failure and 30-day mortality. [37] In an experimental study using CRP as a marker in intestinal ischemia, CRP was found to be more elevated in rats with bacterial translocation. [38] CRP concentrations were also observed to increase parallel with the severity of tissue damage or inflammation in acute intensive infection. [39] In an AMI model study conducted on pigs, the increase in total microflora and bacterial translocation was determined to be consistent with the increase in CRP. [40] Willetts et al. [41] reported high CRP levels in children with acute endotoxinemia with acute invagination, and the finding was correlated to the severity of the disease. Studies of IL-6 have revealed that systemic secretion of TNF-α and IL-6 was related to septic shock and mortal outcomes. It has been reported in a study that TNF-α and IL-6 levels continuously increased following intestinal ischemia, and that these cytokines were secreted from Kuppfer cells. [42] The increase in blood levels of IL-6 in AMI is valuable in demonstrating the early stage onset of systemic response and evaluating the clinical situation of the patients, rather than diagnosing the disease. Another experimental study that compared hemorrhagic shock and intestinal ischemia, no correlation was observed between bacterial translocation and blood levels of cytokines, and IL-6 levels were demonstrated to peak in the third hour after superior mesenteric artery occlusion. [43] In our study, the significant increases in both the CRP and IL-6 levels in the ischemia group were also observed in the third hour, which was earlier than the increase in HBP. However, it should be considered that both CRP and IL-6 are highly non-specific markers and are elevated in many ischemic and inflammatory conditions. Therefore, it is important to note the diagnostic sensitivity and specificity in addition to the ability to be detected in blood at early stages, because the markers studied so far have not been found to be sufficiently sensitive and specific. Since our study was an animal study and included a limited sample, the specificity and sensitivity tests would not produce acceptable statistical results.
Conclusion
This study investigated whether or not HBP, which has been known to have antibacterial effects as well as effects on the early stages of inflammation and vascular permeability, was a beneficial marker in the early diagnosis of acute mesenteric ischemia. Furthermore, the HBP level was compared to the levels of IL-6, which is an important cytokine in inflammatory conditions, and CRP, which is an acute phase reactant induced by IL-6. Although detected later than IL-6 and CRP, a significant increase in the HBP level in the ischemia group in the sixth hour has demonstrated that it could be a potential biomarker in the diagnosis of AMI. However, in order to define the specificity and sensitivity of HBP for AMI, and to determine a cutoff value, clinical studies with larger sample sizes are needed. Combination studies conducted with other markers should be considered as factors to increase the specificity and sensitivity.
